Snowball logo
logo
6883

Chengdu Olymvax Biopharmaceuticals Inc. A

688319 SHG
¥27.97¥0.00  (0%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
487.2547.5496.1588.9704.2774.5
COGS
28.3643.0136.7329.7749.5877.11
Gross Profit
458.8504.5459.4559.1704.2767.3
Operating Expenses & Income
Operating Income
101.641.623.09840921.3130.8667.45
Total Operating Expenses
357.2462.9456.3537.8673.3712.8
R&D Expenses
56.36122114.7134.2132.9180.8
Selling General & Admin Expenses
50.8363.6678.3186.42331174.6
Earnings from Continuing Operations
Interest Expense
(1.361336)(5.156482)(7.235556)(14.52)(14.64)(15.1)
Interest Income
1.4212663.8458672.5536494.5081190.6035570.32745
Income Tax Expense
(0.773645)17.074.1753346.5830139.6614689.661468
Net Income
Net Income
10826.5817.5620.7622.2356.49
Supplemental
EBIT
108.648.8122.8536.8331.89-
EBITDA
131.674.1149.9664.7859.85-
In millions of CNY, except % and values per 1 share